Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 6Gastrointestinal 2Sarcoma 1

Conditions

Sarcoma 35Osteosarcoma 22Central Nervous System Neoplasms 6Breast Neoplasms 6Stomach Neoplasms 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Pancreatic Neoplasms 4Neuroblastoma 4Gliosarcoma 4Glioma 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Astrocytoma 4Wilms Tumor 3Sarcoma, Ewing 3Rhabdomyosarcoma 3Rectal Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Ependymoma 3Desmoplastic Small Round Cell Tumor 3Choroid Plexus Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

Paclitaxel 2Gemcitabine 2seribantumab 1pembrolizumab 1cemiplimab 1camrelizumab 1apatinib 1Radionuclide Imaging 1Quality of Life 1Patient Reported Outcome Measures 1OSI 930 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunotherapy 1Immune Checkpoint Inhibitors 1Fluorodeoxyglucose F18 1FAPI-46 1FANG vaccine 1Drug Therapy 1Doxorubicin 1Docetaxel 1Cisplatin 1Carboplatin 1Bortezomib 1Biological Therapy 1Axitinib 14-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Neoplasms × Cisplatin × Sarcoma × Clear all
NCT00505492 2011-09-15

Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled
GynecologicSarcoma

Carcinosarcoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡